Showing 2071-2080 of 3038 results for "".
- Ashley Magargee Named CEO of Genentechhttps://modernod.com/news/genentech-names-ashley-magargee-as-ceo/2482008/Ashley Magargee has been appointed Chief Executive Officer (CEO) of Genentech, effective January 1, 2024. In addition to her role as Head of US Commercial Portfolio, Ms. Magargee has been serving as ad interim CEO since the departure of Alexander Hardy on November 1, 2023. She will repo
- OIG Publishes General Compliance Program Guidance for the Health Care Industryhttps://modernod.com/news/oig-publishes-general-compliance-program-guidance-for-the-health-care-industry/2481964/According to an advisory from law firm Arnold & Porter, on November 6, the Department of Health and Human Services Office of Inspector General (OIG) released a
- Harrow Completes Transfer of NDAs and Launches Branded Ophthalmic Portfolio in the UShttps://modernod.com/news/harrow-completes-transfer-of-ndas-and-launches-branded-ophthalmic-portfolio-in-the-us/2481906/Harrow announced the completion of the transfer to Harrow of the new drug applications for the following products: Flarex (fluorometholone acetate ophthalmic suspension) 0.1%, a corticosteroid indicated for use in the treatment of steroid-responsive inflamm
- NEI: Scientists Discover External Protein Network Can Help Stabilize Neural Connectionshttps://modernod.com/news/nei-scientists-discover-external-protein-network-can-help-stabilize-neural-connections/2481781/The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons, according to a study in mice from the National Eye Institute (NEI) a
- Verséa Ophthalmics Commences Phase 1 Launch of Novel Tear-Based Point-of-Care (T-POC) Quantitative Testing Platformhttps://modernod.com/news/versea-ophthalmics-commences-phase-1-launch-of-novel-tear-based-point-of-care-t-poc-quantitative-testing-platform/2481745/Verséa Ophthalmics announced the commencement of initial shipments of its T-POC TOTAL IgE Immunoassay and Lateral Flow Readers. T-POC TOTAL IgE Immunoassay Kit is a new quantitative point-of-care test used in the diagnosis and management o
- Harrow Acquires Santen’s Branded Ophthalmic Portfoliohttps://modernod.com/news/harrow-acquires-santens-branded-ophthalmic-portfolio/2481735/Harrow announced it is acquiring certain US and Canadian commercial rights to several branded ophthalmic products from Santen. According to an 8-K filing with the SEC, Harrow will make a one-time upfront payment of $8 million, with future near- and medium-term milestone
- SpyGlass Pharma Completes $90 Million Series C Financing to Advance Novel Treatments for Glaucoma and Other Chronic Ophthalmic Diseaseshttps://modernod.com/news/spyglass-pharma-completes-90-million-series-c-financing-to-advance-novel-treatments-for-glaucoma-and-other-chronic-ophthalmic-diseases/2481711/SpyGlass Pharma announced the closing of $90 million in Series C financing to enable the company to conduct multiple US clinical trials of SpyGlass’ drug delivery platform. The SpyGlass system has the potential to deliver multiple years of medical therapy to address significant unmet n
- Myra Vision Announces Funding to Advance Calibreye Surgical Treatment for Glaucoma Patientshttps://modernod.com/news/myra-vision-raises-money-to-advance-calibreye-surgical-treatment-for-glaucoma-patients/2481694/Myra Vision, which is a Shifamed portfolio company, announced the closing of its $25 million Series B financing to further product development, scale manufacturing capabilities, and support first-in-human investigation of the company's Calibreye System, a novel treatm
- Bruder Healthcare Expands Dry Eye Portfolio with Eye Care Distribution of AllerFocus Percutaneous Allergy Testhttps://modernod.com/news/bruder-healthcare-expands-dry-eye-portfolio-with-eye-care-distribution-of-allerfocus-percutaneous-allergy-test/2481689/Bruder Healthcare announced an eye care industry distribution agreement with Tallahassee, Florida-based AllerFocus for its Percutaneous Allergy Test, a needle-free allergy screening for 78 of the most common airborne and environmental allergens. Financial terms of the deal w
- Peeq Waiva Multipurpose Eyelid Cleansing Device Now Availablehttps://modernod.com/news/peeq-waiva-multipurpose-eyelid-cleansing-device-now-available/2481525/Peeq Pro has announced the launch of the Peeq Waiva, an at-home cleansing device designed for daily use to gently and effectively clean eyelids and the skin around the eyes. When used consistently as part of a patient's at-home eye cleansing routine, the device is designed